Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
3.2M
-
Shares change
-
+617K
-
Total reported value, excl. options
-
$2.44M
-
Value change
-
-$225K
-
Number of buys
-
12
-
Number of sells
-
-11
-
Price
-
$0.76
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q2 2025
39 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q2 2025.
iBio, Inc. - Common Stock (IBIO) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.2M shares
of 22.5M outstanding shares and own 14.26% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (1.54M shares), Ikarian Capital, LLC (600K shares), Opaleye Management Inc. (375K shares), BOOTHBAY FUND MANAGEMENT, LLC (159K shares), VANGUARD GROUP INC (144K shares), GEODE CAPITAL MANAGEMENT, LLC (112K shares), ADAR1 Capital Management, LLC (54.8K shares), BlackRock, Inc. (42.7K shares), Virtu Financial LLC (40.2K shares), and STATE STREET CORP (33.7K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.